Dx & Vx Co., Ltd. (KOSDAQ: A180400)
Health Care · Biotechnology · KR
₩2,330.00
-1.48% today · +11.0% 1Y
Dx & Vx Co., Ltd. (KOSDAQ: A180400) operates in the Biotechnology industry within the Health Care sector. The company is valued at $170.59M.
Over the last twelve months the share price has gained 11.0%, trading between 1.32K and 5.36K.
Tweenvest scores Dx & Vx Co., Ltd. across four factors: quality 57/100, value 60/100. Its strongest factor is value.
A180400 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $170.59M
- Revenue (TTM)
- $16.93M
- P/E
- —
- EPS
- -340.40
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- ₩5,360.00
- 52-week low
- ₩1,319.00
- Avg volume (3M)
- —
- Shares outstanding
- 98.43M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| TYK Medicines, IncSEHK: 2410 | $173.28M | HK$3.54 | -17.79% |
| PepGen Inc.NasdaqGS: PEPG | $172.46M | $2.49 | -4.96% |
| Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.SEHK: 2566 | $172.36M | HK$5.64 | -2.51% |
| ImmuneOnco Biopharmaceuticals (Shanghai) Inc.SEHK: 1541 | $171.05M | HK$3.13 | -7.54% |
| HEM Pharma Inc.KOSDAQ: A376270 | $169.45M | ₩31,600.00 | -9.06% |
| Medigen Biotechnology Corp.TPEX: 3176 | $168.61M | NT$— | — |
| Canton Strategic Holdings, Inc.NasdaqCM: CNTN | $168.13M | $2.11 | 0.00% |
| AptaBio Therapeutics Inc.KOSDAQ: A293780 | $165.92M | ₩7,940.00 | +1.79% |
Figures last refreshed Oct 11, 2026.